Stanford University
Showing 161-180 of 380 Results
-
Feng Jiang
Postdoctoral Scholar, Genetics
BioI am a postdoctoral researcher working on RNA editing.
-
Peter William Earl Kane
Affiliate, Genetics
BioHelping oncology and rare disease patients.
-
Amarnath K R
Affiliate, Genetics
BioAmarnath K R is a computational scientist and deep learning engineer driving breakthroughs in biomedical AI specializing in the fusion of multi-omics data, deep learning, and clinical statistics to tackle some of medicine’s most complex challenges. His current work at Stanford University's Department of Genetics focuses on developing a deep learning framework for cross-modal cell type label transfer by aligning single-cell RNA-seq and proteomics data in a shared latent space. Using autoencoders and a joint contrasitive-based training, he achieves highly reliable annotation of unlabeled proteomics cells with RNA-derived ground truth. This work enables accurate integration of transcriptomic and proteomic modalities for downstream biological discovery and holds promise for expanding cell atlases.
What sets Amarnath apart is his commitment to both technical excellence and translational impact. From designing novel transformer architectures for histopathology and image inpainting, to developing AI-powered tools for emergency departments in India, his work is grounded in real-world deployment and global health relevance. His projects span continents and disciplines like, from integrating multi-omics datasets to uncover disease mechanisms and predict therapeutic response, to an acoustic classifier for biodiversity, to decoding brain function through neuroinformatics.
With multiple publications, international collaborations, and an unwavering drive to innovate, he represents a new generation of computational scientists shaping the future of personalized, data-driven medicine. -
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
Karla Kirkegaard
Violetta L. Horton Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe biochemistry of RNA-dependent RNA polymerase function, the cell biology of the membrane rearrangements induced by positive-strand RNA virus infection of human cells, and the genetics of RNA viruses, which, with their high error rates, live at the brink of error catastrophe, are investigated in the Kirkegaard laboratory.
-
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (Computational Medicine) and, by courtesy, of Genetics
Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer
